poisar

Stocks · News reference

DarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DRIOHIMS
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. SEC EDGAR

    8-K filing — DarioHealth Corp. (DRIO)

    Filed: 2026-09-04 AccNo: 0001104659-26-105495 Size: 186 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    DRIO
  3. Wolf Haldenstein Adler Freeman & Herz Llp

    Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately

    A class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making false statements and failing to disclose that it shares consumers' health information with third-party advertising platforms and charges for prescriptions immediately after intake forms are submitted. The FTC, California, and Utah filed a separate lawsuit on July 29, 2026, resulting in a 14.73% stock price decline.

    HIMS
  4. SEC EDGAR

    8-K filing — Hims & Hers Health, Inc. (HIMS)

    Filed: 2026-10-07 AccNo: 0001773751-26-000220 Size: 142 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    HIMS
  5. Hagens Berman

    Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit—HBSS

    Hims & Hers Health (HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company shared consumers' health data with third-party advertisers like Meta and Snap, charged for prescriptions before medical consultations, and violated ROSCA regulations. The stock dropped 14.7% on July 29, 2026, erasing over $970 million in market value. Investors with substantial losses are encouraged to participate in the class action.

    HIMSMETASNAP
  6. Robbins Llp

    HIMS Stockholders Have Rights – If You Lost Money Investing in Hims & Hers Health, Inc. Contact Robbins LLP for Information About Recovering Your Losses

    Robbins LLP announced a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing customers' protected health information with third-party advertising platforms and engaging in deceptive billing practices. The FTC filed a separate lawsuit on July 29, 2026, which triggered a 14.73% stock decline. Investors who purchased HIMS securities between August 4, 2025 and July 29, 2026 may be eligible to participate in the class action.

    HIMS